United States

Medinet Co Ltd (2370.T)

2370.T on Tokyo Stock Exchange

9:29pm EST
Change (% chg)

¥0 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 2370.T


MEDINET Co., Ltd. is a Japan-based medical support service provider. The Company's main business is divided into three divisions. The immune-cell therapy integrated support service division includes the planning, design, installation, operation, maintenance and management of cell processing centers (CPCs), the licensing of CPCs,... (more)
No analyst recommendations are available for 2370.T.


Beta: 2.02
Market Cap(Mil.): ¥12,974.92
Shares Outstanding(Mil.): 92.68
Dividend: --
Yield (%): --


  2370.T Industry Sector
P/E (TTM): -- 47.00 29.32
EPS (TTM): -17.20 -- --
ROI: -22.58 -4.07 13.03
ROE: -25.20 4.71 14.17

BRIEF-MEDINET receives patent for Method for producing reagent for antibody detection and use thereof in China, Singapore and Taiwan

* Says it acquired patent for “Method for producing reagent for antibody detection and use thereof” in China, Singapore and Taiwan

Feb 12 2017

BRIEF-Medinet to undertake cell processing business

* Says it signed contract with a Japan-based children's hospital and it to undertake the hospital's cell processing business

Oct 30 2016

BRIEF-Medinet receives patent for HSP105 from the US Patent and Trademark Office

* Says the United States Patent and Trademark Office issued the patent for HSP105

Sep 04 2016

More From Around the Web

Earnings vs. Estimates